Search results for " costs"
Article
ADC Development Robust Despite Lackluster Performance
Joint worldwide development costs are funded equally between the two companies, except in Japan where Takeda has full responsibility for development costs (6).
Seattle Genetics has an ADC c…
Article
Witnessing Major Growth in Next-Generation Antibodies
Including next-gen antibodies in pharma pipelines is considered essential for future success.
By Cynthia A. Challener
Next-generation antibodies are designed to be more specific and are ofte…
Article
Automating Bioprocesses
…ze-in-place (SIP) systems employed in stainless-steel equipment systems, which saves initial capital costs and the ongoing production time associated with cleaning and sterilization. The process cont…
Article
Advancing Single-Use Technology Through Collaboration
Single-use systems minimize the risks for cross-contamination between batches, can be set up more quickly than traditional fixed systems, can lower operating costs per batch, and may allow for market …
Article
Process Chromatography Selection for Downstream Processing Applications
Industry experts discuss best practices for selecting a separation technology.
By Caroline Hroncich
Process chromatography has changed significantly since it was first introduced to the biop…
Article
Continuous Processing for the Production of Biopharmaceuticals
With the growing demand for biosimilars and an ever-increasing pressure for reduction in manufacturing costs, the biotech industry seems to exhibit a flourishing interest in the development of continu…
Article
Adherent Cell Culture in Biopharmaceutical Applications: The Cell-Detachment Challenge
Production costs
Expensive cell-detachment systems negatively affect the overall cell-culture process cost and determine the applicability of the technique.
Alternative cell-detachment methods…
Article
Framing Biopharma Success in 2016
At larger R&D companies, legacy infrastructure, which may be difficult to improve, and excess overhead are major contributors to R&D costs. The smaller companies in the study did not have the large in…
Article
CMOs Continue to Improve Overall Biomanufacturing Performance
In 2015, 6 in 10 will increase spending on new technologies to improve efficiencies and costs for downstream production, for an average budget increase of 6.1%. This is likely due to new technologies …
Article
Automated harvesting and 2-step purification of unclarified mammalian cell-culture broths containing antibodies
Therapeutic monoclonal antibodies represent one of the fastest growing segments in the pharmaceutical market. The growth of the segment has necessitated development of new efficient and cost saving …